Medicure (OTCMKTS:MCUJF) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, August 8th.
Medicure (OTCMKTS:MCUJF) last announced its quarterly earnings data on Monday, May 27th. The company reported ($0.14) EPS for the quarter. The firm had revenue of $3.67 million during the quarter. Medicure had a negative return on equity of 0.17% and a negative net margin of 0.50%.
Shares of Medicure stock traded down $0.08 during trading on Tuesday, hitting $3.41. 200 shares of the company were exchanged, compared to its average volume of 935. Medicure has a 1-year low of $3.28 and a 1-year high of $5.68. The stock has a fifty day moving average price of $3.60.
Medicure Company Profile
Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome.
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.